Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2025

Jul 16, 2025

30291_dirs_2025-07-16_282edd2e-c5b9-4306-ab25-6825e81a6f6a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2025-07-08

Reporting Person: Izzar Rachid (Head of Global Product Strat.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-07-08 Common Stock S 2223 $135.00 Disposed 6330 Direct